The 2 most recent market catalysts affecting $NERV, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.
Aug 14, 2026
Corporate Catalyst
Bullish
Impact 75
Minerva Neurosciences shares are trading higher after Jefferies upgraded the stock from Hold to Buy rating and raised the price target from $7.5 to $10.
This headline represents a significant corporate catalyst for Minerva Neurosciences. An upgrade from a reputable firm like Jefferies, coupled with a substantial price target increa…
Aug 14, 2026
Corporate Catalyst
Bullish
Impact 65
Jefferies Upgrades Minerva Neurosciences to Buy, Raises Price Target to $10
Jefferies analyst Biren Amin upgraded Minerva Neurosciences (NERV) from a 'Hold' to a 'Buy' rating and simultaneously raised the price target from $7.50 to $10. This action signals…
Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.